For research and education only · Not reviewed by a medical professional · Disclaimer

Peptide encyclopedia/ Desmopressin
Illustration for Desmopressin

THE PEPSRADAR ENCYCLOPEDIA

Desmopressin

Water conservation through vasopressin-related signaling

Prescription medicines · Sources checked 2026-10-04

Read the studies ↓Explore the molecule ↗

Desmopressin · KEY FACTS

Content updated · how dates work

Saved peptides

Half-life source: FDA label (Desmopressin Acetate) on DailyMed ↗

What is Desmopressin?

Desmopressin is a hormone analogue used in specific water-balance and related conditions. Its effects depend on the formulation and clinical setting.

Biological role or research focus

Water conservation through vasopressin-related signaling.

Its uses concern specific fluid-balance conditions. Product instructions and fluid precautions require clinical guidance.

Role reference: MedlinePlus · Desmopressin ↗

Names you may encounter

DDAVP

Search terms can include brands, combinations, or historical names. They are not automatic product equivalents.

Class / identity
Vasopressin analogue
Main research area
Water conservation
Evidence featured
Human randomized trial
Source check
October 4, 2026

Source: MedlinePlus · Desmopressin ↗

Quick answers

Is Desmopressin FDA approved?
Yes. DDAVP (e.g., NDA 019955) and generics for central diabetes insipidus and primary nocturnal enuresis. Source ↗
Is Desmopressin safe?
Approved antidiuretic hormone drug; its biggest danger is low blood sodium from water retention, which can cause seizures, coma or death if not caught. Human safety data: its FDA label lists the known risks. The Risks & interactions section below lists what is known. Read the risks ↓
Is Desmopressin banned in sport?
Yes. The 2026 World Anti-Doping Agency (WADA) Prohibited List names it (S5 Diuretics and masking agents). Source ↗

What does the evidence show?

Evidence map

Every study featured on this page, grouped by what was actually tested. Human studies count most; animal and cell results often do not carry over to people.

1 Human research
StudyTypePopulation / model
Nocturia formulation study (2012)Human randomized trial757 adults in the intention-to-treat population, mostly with excessive nighttime urine production.

Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.

Human randomized trial · 2012

Nocturia formulation study

Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial.

Population / model
757 adults in the intention-to-treat population, mostly with excessive nighttime urine production.
Study design
Four-week placebo-controlled study of an orally disintegrating formulation.
Main finding
Nighttime voiding decreased and the first sleep period lengthened. Clinically important low sodium occurred in some treatment groups.
Limits & context
Formulation and patient selection matter. This study cannot supply instructions for a different desmopressin product, and fewer bathroom trips must be weighed against hyponatremia risk.

Source: Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial. ↗

Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.

Registered human trials

83 registered studies name Desmopressin as an intervention among the 100 most recently updated of 127 search results; 13 are recruiting or under way, 2 have not started recruiting yet, 46 completed and 22 ended early, were withdrawn or have another status. Checked November 16, 2026 on ClinicalTrials.gov.

StudyStatusPhaseStartPeople
Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia
NCT06020495 · Assistance Publique - Hôpitaux de Paris
RecruitingPhase 32024-12-17260
FESS With or Without Intranasal Desmopressin in Chronic Rhinosinusitis With Nasal Polyps
NCT07855315 · Services Institute of Medical Sciences, Pakistan
Not yet recruitingNot applicable2026-10-15174
Prophylactic Desmopressin Before Native Kidney Biopsy in Severe Renal Impairment
NCT07840313 · Sindh Institute of Urology and Transplantation
CompletedNot applicable2017-08-01250
DDAVP Effect by TEG6 in Cardiac Surgery
NCT07179991 · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Recruiting2026-08-01100
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
NCT06635629 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
RecruitingPhase 22024-12-12140
Bedtime Device Restriction and Desmopressin in PMNE.
NCT07776977 · Al-Azhar University
RecruitingNot applicable2026-08-20140
Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors
NCT07712328 · Zhaoyun Zhang
Enrolling by invitationPhase 42026-06-02152
Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial
NCT06337838 · Hamilton Health Sciences Corporation
RecruitingPhase 32025-06-09100

A registration shows a study was planned; it is not a result. Some studies use the compound only as a comparison or in a combination. All 83 listed studies.

Further reading · 4 additional publication links

Exact-name PubMed search checked 2026-10-04. These records have not been appraised. A name match can include related compounds, combinations, or other formulations; it does not establish safety or benefit.

Desmopressin. ↗
· 2006 · Review

Desmopressin. ↗
· 2023 Jan · Study Guide

Desmopressin and antifibrinolytics. ↗
International anesthesiology clinics · 1990 Fall · Journal Article, Review

Intranasal desmopressin-induced hyponatremia. ↗
Pharmacotherapy · 1996 Jan-Feb · Case Reports, Journal Article, Review

Repeat this PubMed search ↗
Search additional PubMed records ↗

Risks & interactions

Approved antidiuretic hormone drug; its biggest danger is low blood sodium from water retention, which can cause seizures, coma or death if not caught.

Human safety data: FDA label

This entry follows the label for one brand (Desmoda); desmopressin is sold in several forms, and some other desmopressin products carry a boxed warning for low sodium. Evidence comes from clinical studies and postmarketing reports.

Take extra care with: Heart or blood pressure problemsKidney problems

From the FDA label lists below. If a condition applies to you, talk to a doctor or pharmacist first. Each tag opens every profile that mentions it.

Who should not use it

  • People with low blood sodium now or in the past
  • People allergic to desmopressin or any ingredient
  • People with moderate to severe kidney impairment

Interactions

  • SSRI or tricyclic antidepressants and chlorpromazine: higher risk of low sodium
  • Thiazide diuretics, NSAIDs and opioid pain relievers: higher risk of low sodium
  • Carbamazepine, lamotrigine, chlorpropamide and oxybutynin: higher risk of low sodium
  • Other blood-vessel-narrowing drugs (vasoconstrictors): blood pressure may rise

Serious risks

  • Low blood sodium (water intoxication) that can cause seizures, coma, breathing arrest or death
  • Higher low-sodium risk in children, older adults, and during illness, heat, hard exercise or heavy fluid intake
  • Fluid retention that can worsen heart failure or uncontrolled high blood pressure
  • Severe allergic reactions, including fatal anaphylaxis reported with other desmopressin forms
  • Toxicity risk in newborns from a benzyl alcohol-related preservative in this product

Common side effects

  • headache
  • nausea
  • vomiting
  • diarrhea
  • abdominal cramps
  • fatigue
  • dizziness
  • swelling

Summarized from the FDA label with AI assistance; not reviewed by a clinician. Not a complete list, and not medical advice: talk to a doctor or pharmacist about your own situation. Checked 2026-10-10. Sources: DailyMed: Desmoda (desmopressin acetate) prescribing information ↗

Key precautions

Retaining too much water can lower blood sodium dangerously. Fluid intake, kidney function, interacting medicines, and sodium monitoring are central clinical considerations.

Source: MedlinePlus · Desmopressin ↗

Regulatory status

U.S. FDA approval
Approved
DDAVP (e.g., NDA 019955) and generics for central diabetes insipidus and primary nocturnal enuresis; Desmoda (NDA 219873) approved February 2026. Several older brands (Stimate, Noctiva, Nocdurna, Minirin) are listed as discontinued. source
FDA compounding (503A bulk list)
Not on FDA’s compounding lists
Not on FDA's 503A nominated-substance category lists. As a component of an FDA-approved drug it does not need to be on the 503A bulks list to be used in pharmacy compounding (other 503A conditions still apply). source
World Anti-Doping Agency (2026)
Prohibited, named on the list · S5 Diuretics and masking agents
Named explicitly ("Desmopressin") as a masking agent; prohibited at all times. source

Checked October 28, 2026. Rules change; follow the source links for the current status. Regulatory tracker.

This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.

Clinical uses & product context

The oral medication reference covers central diabetes insipidus, certain post-injury or postsurgical symptoms, and bedwetting. The study below concerns a distinct orally disintegrating nocturia formulation. Their instructions are not interchangeable.

Source: MedlinePlus · Desmopressin ↗

New editorial updates

Loading approved updates…

New source discoveries

Links appear automatically. Unreviewed discoveries are not verified medical findings.

Loading recent discoveries…

Explore the latest source feed →

Sources & supplier listings

Why there are no prices here

This is a prescription medicine, available only with a prescription through a pharmacy. Versions sold online as "research" products are not the approved medicine, and the FDA has warned sellers of them, so PepsRadar does not list, compare or link them. See the official product information linked in References.

Mechanism & research rationale

It replaces aspects of vasopressin signaling, helping the body conserve water and balance salt and fluid. This concerns water handling rather than glucose lowering.

Source: MedlinePlus · Desmopressin ↗

Molecular structure

Desmopressin: 2d molecular structure. The cited molecular record is shown. Salts, protonation, and formulation ingredients may differ from a specific product.⤢ Enlarge 2D
2D molecular structureThe cited molecular record is shown. Salts, protonation, and formulation ingredients may differ from a specific product.PubChem · CID 5311065 ↗

Questions worth asking

  • Which indication and formulation does the source describe?
  • Does the video make a broader claim than the source supports?
  • Its uses concern specific fluid-balance conditions. Product instructions and fluid precautions require clinical guidance.
  • What adverse effects, uncertainty, and conflicts of interest does the original source report?

Frequently asked questions

Is diabetes insipidus the same as diabetes mellitus?

No. The former concerns water regulation; the latter concerns blood-glucose regulation.

Source: MedlinePlus · Desmopressin ↗

Can one formulation’s study determine another product’s use?

No. Product-specific absorption, indication, and precautions must be checked.

Source: Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial. ↗

References & editorial record

Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation.

For research and education only. This page does not provide medical advice, diagnosis, or treatment. Research-only listings are not instructions for human use.

See something wrong on this page? Report a mistake · Corrections

MOLECULAR ATLAS

Desmopressin

Download illustration ↓Source record ↗
Desmopressin 2d molecular structure

The cited molecular record is shown. Salts, protonation, and formulation ingredients may differ from a specific product.